Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Brown

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Frontiers in Pharmacology|April 4, 2022
Editorial: Vitamin D and COVID-19: New Mechanistic and Therapeutic InsightsEwa Marcinkowska, Geoffrey Brown
Trends in Immunology|August 25, 2009
Lineage determination in haematopoiesis: quo vadis?Geoffrey Brown, Rhodri Ceredig
Frontiers in Cell and Developmental Biology|August 13, 2024
Editorial: Editors' showcase: insights in cancer cell biologyGeoffrey Brown, Andrew Liss
Leukemia Research and Treatment|December 6, 2012
Retinoid differentiation therapy for common types of acute myeloid leukemiaGeoffrey Brown, Philip Hughes
Cell Cycle (Georgetown, Tex.)|January 25, 2011
A combination of 1α,25-dihydroxyvitamin D3, a plant-derived antioxidant and an inhibitor of the Cot1/Tlp2 oncogene as molecularly targeted weapons in the hematologist's battle against acute myeloid leukemiasPhilip J Hughes, Geoffrey Brown
Journal of Cellular Biochemistry|January 28, 2006
1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathwayPhilip J Hughes, Geoffrey Brown
Frontiers in Cell and Developmental Biology|March 27, 2023
Editorial: Targeted therapies for aggressive cancersSean B Lee, Geoffrey Brown
Leukemia Research|May 12, 2009
Interplay between signalling pathways mediates 1,25alpha-dihydroxyvitamin D3-driven monocytic differentiation--JNKs are importantPhilip J Hughes, Geoffrey Brown
Oncotarget|October 27, 2015
Is lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?Geoffrey Brown, Isidro Sanchez-Garcia
Leukemia Research|April 27, 2012
A role for caspase inhibitors in differentiation therapy of myeloid leukaemiaGeoffrey Brown, Philip J Hughes
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Frontiers in Pharmacology|April 4, 2022
Editorial: Vitamin D and COVID-19: New Mechanistic and Therapeutic InsightsEwa Marcinkowska, Geoffrey Brown
Trends in Immunology|August 25, 2009
Lineage determination in haematopoiesis: quo vadis?Geoffrey Brown, Rhodri Ceredig
Frontiers in Cell and Developmental Biology|August 13, 2024
Editorial: Editors' showcase: insights in cancer cell biologyGeoffrey Brown, Andrew Liss
Leukemia Research and Treatment|December 6, 2012
Retinoid differentiation therapy for common types of acute myeloid leukemiaGeoffrey Brown, Philip Hughes
Cell Cycle (Georgetown, Tex.)|January 25, 2011
A combination of 1α,25-dihydroxyvitamin D3, a plant-derived antioxidant and an inhibitor of the Cot1/Tlp2 oncogene as molecularly targeted weapons in the hematologist's battle against acute myeloid leukemiasPhilip J Hughes, Geoffrey Brown
Journal of Cellular Biochemistry|January 28, 2006
1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathwayPhilip J Hughes, Geoffrey Brown
Frontiers in Cell and Developmental Biology|March 27, 2023
Editorial: Targeted therapies for aggressive cancersSean B Lee, Geoffrey Brown
Leukemia Research|May 12, 2009
Interplay between signalling pathways mediates 1,25alpha-dihydroxyvitamin D3-driven monocytic differentiation--JNKs are importantPhilip J Hughes, Geoffrey Brown
Oncotarget|October 27, 2015
Is lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?Geoffrey Brown, Isidro Sanchez-Garcia
Leukemia Research|April 27, 2012
A role for caspase inhibitors in differentiation therapy of myeloid leukaemiaGeoffrey Brown, Philip J Hughes
Pageof 10